Daiichi Sankyo
4 followers
Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Daiichi Sankyo Group and Ranbaxy Group. The Daiichi Sankyo Group segment comprises of Daiichi Sankyo Co., Ltd. and its subsidiaries. The Ranbax... Read more
Org chart
Ken Keller
Chairman, President & CEO
Ken Keller
Collapse
Raquel Coca Lopez
Chief Commercial Officer (cco)
Simon King
Chief People Officer
Patricia A. Barbieri
SVP, General Counsel & Secretary
Kara Reheis
Vice President, Marketing
Scott Cleve
Vice President, Regulatory Operations, Information And Compliance
Brian Hauser
VP, U.S. Business Operations
Mila Tartakovsky
Head of US Finance & Global Oncology Finance
Rich Jones
VP, Global Oncology Business Strategy & Analytics
James Felix
Head of Global Digital Transformation, Chief Digital Transformation Officer
Lerryn Trzcinski
VP, U.S. Market Access
Ken Takeshita
Global Head of Research & Development
Hayes Williams
Global Head Of The Center For Data Governance
Michael Grosso
Global Head of Specialty Medicine Clinical Development
Stu Mackey
Global Head, Business Development
Barbara Tantillo Rn Bsn
Head Audits And Compliance
Michele Schmidt
Head Of Asset And Portfolio Management
Dale E. Shuster
Head of Global Precision Medicine
Daniel Switzer
Head of U.S. Oncology Business Division
Barry Fortner
VP, US Medical Affairs
Mary Pinder-Schenck
Head of Global Oncology Medical Affairs
Matt Siegel
National Sales Director, Hematology & Supportive Care
Kevin R Forrest
National Sales Director, Oncology Breast
Fussy Tracy
National Sales Director, Oncology Lung
